Cargando…

Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas

BACKGROUND: The use of (18)F-FDG Positron emission tomography/Computed tomography (PET/CT) in the initial staging of many cancers is clearly established. Most soft tissue sarcoma (STS) has a high affinity for (18)F-FDG, which is why (18)F-FDG PET/CT has been proposed as a non-invasive method, useful...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes Marlés, Rafael Hernando, Navarro Fernández, José Luis, Puertas García-Sandoval, José Pablo, Santonja Medina, Fernando, Mohamed Salem, Laroussi, Frutos Esteban, Laura, Contreras Gutiérrez, José Fulgencio, Castellón Sánchez, María Isabel, Ruiz Merino, Guadalupe, Claver Valderas, María Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413431/
https://www.ncbi.nlm.nih.gov/pubmed/34476632
http://dx.doi.org/10.1186/s41824-021-00110-5
_version_ 1783747658146381824
author Reyes Marlés, Rafael Hernando
Navarro Fernández, José Luis
Puertas García-Sandoval, José Pablo
Santonja Medina, Fernando
Mohamed Salem, Laroussi
Frutos Esteban, Laura
Contreras Gutiérrez, José Fulgencio
Castellón Sánchez, María Isabel
Ruiz Merino, Guadalupe
Claver Valderas, María Antonia
author_facet Reyes Marlés, Rafael Hernando
Navarro Fernández, José Luis
Puertas García-Sandoval, José Pablo
Santonja Medina, Fernando
Mohamed Salem, Laroussi
Frutos Esteban, Laura
Contreras Gutiérrez, José Fulgencio
Castellón Sánchez, María Isabel
Ruiz Merino, Guadalupe
Claver Valderas, María Antonia
author_sort Reyes Marlés, Rafael Hernando
collection PubMed
description BACKGROUND: The use of (18)F-FDG Positron emission tomography/Computed tomography (PET/CT) in the initial staging of many cancers is clearly established. Most soft tissue sarcoma (STS) has a high affinity for (18)F-FDG, which is why (18)F-FDG PET/CT has been proposed as a non-invasive method, useful in diagnosis and follow-up. The standardized uptake value values (SUV), the volume-based metabolic parameters MTV (metabolic tumor volume), and TLG (total lesion glycolysis) determine tumor viability and provide its total volume and the total activity of metabolically active tumor cells. The histological grade is the most important predictor of metastases and mortality associated with STS, and a significant relationship between the metabolic parameters of (18)F-FDG PET/CT and the histological grade has been described. METHODS: A retrospective study was conducted on STS patients, who had histological grade according to the FNCLCC (Fédération Nationale des Centres de Lutte Contre Le Cancer) criteria, as well as a baseline PET/CT. SUV (SUV(max), SUV(mean), and SUV(peak)), MTV, and TLG were quantified. A T-student test was performed to establish the relationship between the metabolic biomarkers and the histological grade. Their usefulness as predictors of the histological grade was verified using receiver operator characteristic (ROC) curves. A survival function study was performed using the Kaplan–Meier method. To assess the prognostic utility of the metabolic biomarkers we use the Log-Rank method. RESULTS: The SUV values were useful to discriminate high-grade STS. We found a significant relationship between the histological grade and the SUV values. SUV(max), SUV(peak), MTV, and TLG were predictors of overall survival (OS). There were no significant differences in the OS for the SUV(mean), or in the disease-free survival (DFS) for SUV(max), SUV(mean), SUV(peak), MTV, and TLG. CONCLUSIONS: The SUV(max), SUV(mean), and SUV(peak) values correlate with the HG and are useful to discriminate high-grade from low-grade STS. Patients with high SUV(max), SUV(peak), MTV, and TLG have a significantly lower OS.
format Online
Article
Text
id pubmed-8413431
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84134312021-09-22 Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas Reyes Marlés, Rafael Hernando Navarro Fernández, José Luis Puertas García-Sandoval, José Pablo Santonja Medina, Fernando Mohamed Salem, Laroussi Frutos Esteban, Laura Contreras Gutiérrez, José Fulgencio Castellón Sánchez, María Isabel Ruiz Merino, Guadalupe Claver Valderas, María Antonia Eur J Hybrid Imaging Original Article BACKGROUND: The use of (18)F-FDG Positron emission tomography/Computed tomography (PET/CT) in the initial staging of many cancers is clearly established. Most soft tissue sarcoma (STS) has a high affinity for (18)F-FDG, which is why (18)F-FDG PET/CT has been proposed as a non-invasive method, useful in diagnosis and follow-up. The standardized uptake value values (SUV), the volume-based metabolic parameters MTV (metabolic tumor volume), and TLG (total lesion glycolysis) determine tumor viability and provide its total volume and the total activity of metabolically active tumor cells. The histological grade is the most important predictor of metastases and mortality associated with STS, and a significant relationship between the metabolic parameters of (18)F-FDG PET/CT and the histological grade has been described. METHODS: A retrospective study was conducted on STS patients, who had histological grade according to the FNCLCC (Fédération Nationale des Centres de Lutte Contre Le Cancer) criteria, as well as a baseline PET/CT. SUV (SUV(max), SUV(mean), and SUV(peak)), MTV, and TLG were quantified. A T-student test was performed to establish the relationship between the metabolic biomarkers and the histological grade. Their usefulness as predictors of the histological grade was verified using receiver operator characteristic (ROC) curves. A survival function study was performed using the Kaplan–Meier method. To assess the prognostic utility of the metabolic biomarkers we use the Log-Rank method. RESULTS: The SUV values were useful to discriminate high-grade STS. We found a significant relationship between the histological grade and the SUV values. SUV(max), SUV(peak), MTV, and TLG were predictors of overall survival (OS). There were no significant differences in the OS for the SUV(mean), or in the disease-free survival (DFS) for SUV(max), SUV(mean), SUV(peak), MTV, and TLG. CONCLUSIONS: The SUV(max), SUV(mean), and SUV(peak) values correlate with the HG and are useful to discriminate high-grade from low-grade STS. Patients with high SUV(max), SUV(peak), MTV, and TLG have a significantly lower OS. Springer International Publishing 2021-09-03 /pmc/articles/PMC8413431/ /pubmed/34476632 http://dx.doi.org/10.1186/s41824-021-00110-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Reyes Marlés, Rafael Hernando
Navarro Fernández, José Luis
Puertas García-Sandoval, José Pablo
Santonja Medina, Fernando
Mohamed Salem, Laroussi
Frutos Esteban, Laura
Contreras Gutiérrez, José Fulgencio
Castellón Sánchez, María Isabel
Ruiz Merino, Guadalupe
Claver Valderas, María Antonia
Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
title Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
title_full Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
title_fullStr Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
title_full_unstemmed Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
title_short Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
title_sort clinical value of baseline (18)f-fdg pet/ct in soft tissue sarcomas
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413431/
https://www.ncbi.nlm.nih.gov/pubmed/34476632
http://dx.doi.org/10.1186/s41824-021-00110-5
work_keys_str_mv AT reyesmarlesrafaelhernando clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas
AT navarrofernandezjoseluis clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas
AT puertasgarciasandovaljosepablo clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas
AT santonjamedinafernando clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas
AT mohamedsalemlaroussi clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas
AT frutosestebanlaura clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas
AT contrerasgutierrezjosefulgencio clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas
AT castellonsanchezmariaisabel clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas
AT ruizmerinoguadalupe clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas
AT clavervalderasmariaantonia clinicalvalueofbaseline18ffdgpetctinsofttissuesarcomas